HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
Amy A. Scott, David R. Head, Kenneth J. Kopecky, Frederick R. Appelbaum, Karl S. Theil, Michael R. Grever, I. Ming Chen, Michael H. Whittaker, Barbara B. Griffith, Jonathan D. Licht, Samuel Waxman, Margaret M. Whalen, Arthur D. Bankhurst, Lynn C. Richter, Thomas M. Grogan, Cheryl L. Willman
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3'. Together they form a unique fingerprint.